A low dose of the Pfizer-BioNTech coronavirus vaccine failed to produce an adequate response in children aged two through five years of age.
The companies
A syringe is prepared with the Pfizer COVID-19 vaccine at a clinic in the Norristown Public Health Center in Norristown, Pa., Tuesday, Dec. 7, 2021. "The companies will amend the clinical study evaluating the safety, tolerability, and immunogenicity of the Pfizer-BioNTech COVID-19 Vaccine in children 6 months to under 5 years of age," the statement said.
Germaine T. Leftwich, 67, receives a Pfizer covid-19 vaccine booster shot from Dr. Tiffany Taliaferro at the Safeway on Capitol Hill in Washington, D.C., on Monday, October 4, 2021.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer and BioNTech ask FDA to approve their Covid-19 vaccine for kids as young as 12The companies submitted Phase III clinical trial data to FDA as a supplemental application for their vaccine, which is already approved for adults and children as young as 16.
Read more »
Pfizer files for full FDA approval of COVID-19 vaccine in adolescentsPfizer Inc and its German partner BioNTech SE said on Thursday they have filed for full approval of their COVID-19 vaccine with the U.S. Food and Drug Administration to include adolescents aged 12 to 15.
Read more »
CDC Panel Recommends Pfizer, Moderna Vaccines Over J&J ShotU.S. health advisers are recommending that most Americans get the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot.
Read more »
CDC panel recommends people not get J&J vaccine if Pfizer, Moderna availablePeople shouldn’t get the Johnson & Johnson COVID-19 vaccine when the Pfizer-BioNTech and Moderna shots are available, an advisory panel to the CDC said.
Read more »
CDC recommends people not get J&J vaccine if Pfizer, Moderna are availableThe advisory committee voted in favor of language that calls the mRNA vaccines from Pfizer and Moderna the 'preferred' options over Johnson & Johnson's.
Read more »